These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 23983273

  • 1. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
    Dassios TG, Katelari A, Doudounakis S, Dimitriou G.
    Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Maximum rate of pressure development and maximal relaxation rate of respiratory muscles in patients with cystic fibrosis.
    Dassios TG, Doudounakis S, Dimitriou G.
    Respir Care; 2013 Mar; 58(3):474-81. PubMed ID: 22781492
    [Abstract] [Full Text] [Related]

  • 5. Inspiratory Muscle Strength and Endurance in Children and Adolescents with Cystic Fibrosis.
    Vendrusculo FM, Heinzmann-Filho JP, Piva TC, Marostica PJ, Donadio MV.
    Respir Care; 2016 Feb; 61(2):184-91. PubMed ID: 26604327
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR, Pressler T, Høiby N.
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [Abstract] [Full Text] [Related]

  • 13. Mucus removal is impaired in children with cystic fibrosis who have been infected by Pseudomonas aeruginosa.
    Laube BL, Sharpless G, Benson J, Carson KA, Mogayzel PJ.
    J Pediatr; 2014 Apr; 164(4):839-45. PubMed ID: 24373575
    [Abstract] [Full Text] [Related]

  • 14. Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection.
    Hector A, Schäfer H, Pöschel S, Fischer A, Fritzsching B, Ralhan A, Carevic M, Öz H, Zundel S, Hogardt M, Bakele M, Rieber N, Riethmueller J, Graepler-Mainka U, Stahl M, Bender A, Frick JS, Mall M, Hartl D.
    Am J Respir Crit Care Med; 2015 Apr 15; 191(8):914-23. PubMed ID: 25632992
    [Abstract] [Full Text] [Related]

  • 15. [Indirect evaluation of respiratory muscle strength with the help of markers of maximal inspiratory and expiratory pressure in the mouth of healthy individuals].
    Adamiak-Kardas M.
    Pol Merkur Lekarski; 2002 Mar 15; 12(69):178-80. PubMed ID: 12053582
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.
    Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K.
    J Pediatr; 2001 May 15; 138(5):699-704. PubMed ID: 11343046
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML.
    JAMA; 2005 Feb 02; 293(5):581-8. PubMed ID: 15687313
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
    Taccetti G, Campana S, Festini F, Mascherini M, Döring G.
    Eur Respir J; 2005 Sep 02; 26(3):458-61. PubMed ID: 16135728
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.